PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1.89%
Both yoy net incomes decline, with BB at -281.82%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
51.98%
D&A growth of 51.98% while BB is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-199.65%
Negative yoy deferred tax while BB stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
12.80%
SBC growth well above BB's 22.22%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-525.97%
Negative yoy working capital usage while BB is 61.45%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-126.74%
Both yoy AR lines negative, with BB at -433.33%. Martin Whitman would suspect an overall sector lean approach or softer demand.
391.88%
Inventory growth well above BB's 84.51%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-307.66%
Negative yoy AP while BB is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
32.42%
Growth well above BB's 33.33%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
1314.29%
Some yoy increase while BB is negative at -105.95%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-38.35%
Both yoy CFO lines are negative, with BB at -156.57%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
1.84%
Lower CapEx growth vs. BB's 70.00%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-5383.05%
Both yoy lines negative, with BB at -75.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
49.67%
Purchases well above BB's 61.19%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-72.68%
We reduce yoy sales while BB is 266.67%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
237.17%
Growth well above BB's 75.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-14399.20%
We reduce yoy invests while BB stands at 400.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-94.40%
We cut debt repayment yoy while BB is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-61.90%
Both yoy lines negative, with BB at -100.89%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
17.20%
Buyback growth of 17.20% while BB is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.